Abiopharma

🔍 Fields Kimberly A (Executive)

Company: ATI INC (ATI)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Sold 1,300 shares of Common Stock, par value $0.10 per share at $154.02 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 316,463.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,568 shares of Common Stock, par value $0.10 per share at $156.29 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 310,895.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,350 shares of Common Stock, par value $0.10 per share at $157.51 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 307,545.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 6,420 shares of Common Stock, par value $0.10 per share at $158.38 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 301,125.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,600 shares of Common Stock, par value $0.10 per share at $159.38 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 298,525.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 11,982 shares of Common Stock, par value $0.10 per share at $160.6 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 286,543.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 8,780 shares of Common Stock, par value $0.10 per share at $161.12 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 277,763.00 | transaction_form_type: 4 | Footnotes: F1, F8

Footnotes:

• F1: Shares sold pursuant to a 10b5-1 Trading Plan dated February 5, 2026, entered into for personal tax and estate planning purposes.
• F2: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.82 to $154.65. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F3: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.78 to $156.76. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F4: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.91 to $157.90. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.91 to $158.88. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.94 to $159.84. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.99 to 160.98. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.
• F8: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.99 to 161.38. The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.